LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 84.45 | 84.90 | 1188 | 8254 | 0.1439 | 0.4912 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 86.16 | 84.90 | 1457 | 8141 | 0.1790 | 0.5400 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 86.16 | 84.90 | 1506 | 8141 | 0.1850 | 0.5478 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 86.16 | 84.90 | 1169 | 8141 | 0.1436 | 0.4894 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 86.16 | 84.90 | 1189 | 8141 | 0.1460 | 0.4932 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 87.86 | 84.90 | 1456 | 7680 | 0.1896 | 0.5485 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 87.86 | 84.90 | 1533 | 7680 | 0.1996 | 0.5608 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 87.86 | 84.90 | 1179 | 7680 | 0.1535 | 0.4990 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 87.86 | 84.90 | 1208 | 7680 | 0.1573 | 0.5046 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 89.57 | 84.90 | 1406 | 7494 | 0.1876 | 0.5438 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 89.57 | 84.90 | 1520 | 7494 | 0.2028 | 0.5626 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 89.57 | 84.90 | 1205 | 7494 | 0.1608 | 0.5074 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 89.57 | 84.90 | 1228 | 7494 | 0.1639 | 0.5118 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 91.27 | 84.90 | 1339 | 7420 | 0.1805 | 0.5337 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 91.27 | 84.90 | 1554 | 7420 | 0.2094 | 0.5695 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 91.27 | 84.90 | 1204 | 7420 | 0.1623 | 0.5086 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 91.27 | 84.90 | 1226 | 7420 | 0.1652 | 0.5128 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 92.98 | 84.90 | 1201 | 7257 | 0.1655 | 0.5111 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 92.98 | 84.90 | 1558 | 7257 | 0.2147 | 0.5736 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 92.98 | 84.90 | 1206 | 7257 | 0.1662 | 0.5121 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 92.98 | 84.90 | 1228 | 7257 | 0.1692 | 0.5164 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 94.68 | 84.90 | 1090 | 7000 | 0.1557 | 0.4933 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 94.68 | 84.90 | 1578 | 7000 | 0.2254 | 0.5827 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 94.68 | 84.90 | 1219 | 7000 | 0.1741 | 0.5198 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 94.68 | 84.90 | 1238 | 7000 | 0.1769 | 0.5235 | MN20160318_Q02 | F10 |